AstraZeneca pulls Covid-19 vaccine globally as the pharma sees 'no future commercial demand'
AstraZeneca is withdrawing its Oxford-collaborated Covid-19 vaccine from global markets, the UK-based pharma company confirmed in a statement to Endpoints News on Tuesday.
The spokesperson said AstraZeneca no longer manufactures or supplies the vaccine, which was first cleared for emergency supply in the UK in December 2020 and had since been delivered to more than 180 countries.
“As multiple, variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines,” the AstraZeneca spokesperson said in an emailed statement. “This has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied. We will partner with regulatory authorities globally to initiate marketing authorization withdrawals for Vaxzevria, where no future commercial demand for the vaccine is expected.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
